Hirsutism, drug-induced

L12_HIRSUTISM_ADVERSE

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ATC codes for adverse effects of Drugs — ANY Hospital discharge: ICD-10 — L68.0# 1 out of 7 registries used, show all original rules.	67
4. Check minimum number of events None	67
5. Include endpoints None	67
6. Filter based on genotype QC (FinnGen only)	67

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF5
Parent code in ICD-10: L68
Name in latin: Hirsutismus

NAME	L12_HIRSUTISM_ADVERSE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC	ANY
HD_ICD_10	L680
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hirsutism, drug-induced based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (not available in FinRegistry).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	67	67	-
Unadjusted period prevalence (%)	0.02	0.02	-
Median age at first event (years)	32.97	32.97	-

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
62: Matched controls
620

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L68.0

ICD-10 Finland

Hirsutism

+∞

82.0

G03HB01

ATC

cyproterone and estrogen; systemic

12.4

16.9

C03DA01

ATC

spironolactone; oral

10.5

9.2

G03DB01

ATC

dydrogesterone; oral

4.7

7.3

103

A10BK03

ATC

empagliflozin; oral

19.5

7.0

T90

ICPC

Diabetes non-insulin dependent

6.2

6.9

XLA10

NOMESCO Finland

6.1

6.2

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020682) Albumin/Creatinine [Ratio] in Urine

110

3.23

4.84

3.7

3.3

1.0

5.8

mg/mmol

0.83

(3012516) Albumin [Mass/volume] in Urine

108

3.10

4.45

3.2

2.7

6.7

27.8

mg/l

—

(4034850)

4.47

2.43

5.3

6.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

0.00

2.39

0.0

3.8

—

32.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

3.80

2.35

1.0

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

3.80

2.35

1.0

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

3.80

2.35

1.0

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2.49

2.31

2.3

3.0

5.4

228.4

ng/l

—

(3025941) Bacteria identified in Stool by Culture

3.00

2.21

1.3

1.2

—

(3044889) 12 lead EKG panel

380

2.08

1.87

3.7

2.9

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

3.27

1.85

1.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

131

2.01

1.78

2.0

1.7

0.6

0.8

mg/l

0.31

104

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.62

1.77

2.5

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.56

1.69

2.5

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3.77

1.64

2.2

1.4

60.2

103.6

ng/l

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

129

1.91

1.54

1.3

8.0

30.5

iu/ml

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

191

1.80

1.48

2.1

1.7

86.7

99.4

pmol/l

0.65

106

(3004716) Salmonella sp identified in Stool by Organism specific culture

2.44

1.47

1.1

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

3.29

1.46

1.4

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

3.09

1.38

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.53

1.27

1.3

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

142

1.70

1.10

1.4

1.3

2.9

2.0

u/ml

—

(4010399)

2.25

1.09

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.93

1.09

2.3

1.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

341

1.62

1.06

8.2

8.8

4.2

3.9

e9/l

0.24

301

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

101

1.77

1.05

1.4

2.6

143.5

413.9

ng/l

1.21

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2.11

1.03

1.7

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

0.00

0.99

0.0

1.5

—

295.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

191

1.59

0.98

4.1

3.1

2.4

mmol/l

0.53

178

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.98

0.0

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

112

1.69

0.97

1.2

1.4

25.4

21.9

nmol/l

0.42

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

133

1.60

0.86

1.3

1.1

10.4

u/ml

1.24

(3003694) ABO and Rh group [Type] in Blood

159

0.56

0.86

1.7

1.5

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

169

1.55

0.85

5.5

2.6

—

(3031040) Bacteria [#/volume] in Urine by Automated count

363

1.52

0.82

5.0

4.0

—

677.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.82

0.81

1.4

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

0.00

0.81

0.0

3.3

—

4.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

183

1.49

0.74

2.1

3.1

8.6

18.0

ng/l

2.24

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

130

0.56

0.73

2.4

2.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

433

1.49

0.68

3.8

2.9

43.8

37.5

u/l

0.45

416

(3019198) Lymphocytes [#/volume] in Blood

301

1.42

0.68

3.4

4.3

2.1

1.9

e9/l

0.86

269

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

111

0.59

0.65

1.1

1.6

—

(3000330) Specific gravity of Urine by Test strip

0.00

0.61

0.0

2.0

—

(3045414) Leukocytes [Presence] in Urine

0.00

0.61

0.0

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

264

0.70

0.61

4.4

4.0

—

(3000492) Spirometry study

1.58

0.61

2.0

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

168

0.65

0.60

2.3

2.1

—

(40768443) Skin Pathology biopsy report

0.00

0.60

0.0

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

535

1.63

0.59

10.6

9.6

86.8

87.9

ml/min/173m2

0.18

435

(3009542) Hematocrit [Volume Fraction] of Blood

562

1.65

0.54

16.2

10.9

41.9

40.0

3.46

465

(3026008) Bacteria identified in Urine by Culture

156

1.40

0.53

2.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

157

1.39

0.51

1.9

3.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1.44

0.46

2.5

2.6

2.5

2.4

mmol/l

0.46

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.42

0.0

1.4

—

(3049717) Cytology report of Urine Cyto stain

0.00

0.42

0.0

1.5

—

(3022313) Gas panel - Capillary blood

0.00

0.41

0.0

3.1

—

(3022621) pH of Urine by Test strip

1.51

0.41

2.4

1.9

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.40

0.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.40

0.0

1.1

—

(3013512) EKG study

134

0.70

0.40

1.7

2.3

—

(3002256) Pathology report gross observation

0.68

0.35

1.0

1.2

—

(40768797) Stomach Pathology biopsy report

1.41

0.34

1.4

1.1

—

(36304419) Bacteria [Presence] in Urine

129

1.32

0.34

6.7

2.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

120

1.32

0.34

3.4

3.7

—

(40758558) Short blood count panel - Blood

139

1.30

0.33

8.6

7.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

216

1.25

0.32

3.0

3.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

129

0.74

0.32

1.6

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

140

1.29

0.31

1.8

1.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

447

1.26

0.31

7.2

6.4

74.2

75.3

u/l

0.11

413

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.34

0.30

1.6

1.7

—

(21494755) Public health laboratory ask at order entry panel

1.37

0.30

1.1

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

160

1.26

0.30

1.9

2.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

0.66

0.27

1.0

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

0.66

0.27

1.8

1.7

—

(3023368) Bacteria identified in Blood by Culture

106

1.28

0.25

4.0

3.8

—

(40768804) Tissue Pathology biopsy report

249

0.83

0.24

2.2

2.0

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.34

0.24

11.0

6.6

102.6

104.2

mmol/l

—

(40761535) Cells panel - Urine sediment

1.27

0.23

2.6

4.0

—

(3008898) HLA-B27 [Presence]

1.21

0.22

1.0

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

0.00

0.21

0.0

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

0.21

0.0

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.21

0.0

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

0.00

0.21

0.0

2.6

—

3.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.30

0.21

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

0.00

0.21

0.0

3.5

—

25.1

—

(3021589) Normoblasts [#/volume] in Blood

254

1.18

0.21

5.4

7.2

0.0

e9/l

0.86

204

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.4

—

(36660697) Celiac disease serology panel - Serum

1.19

0.20

1.5

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.19

0.18

1.7

1.6

—

(3042936) Bacteria identified in Isolate by Culture

1.16

0.18

1.4

2.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

296

1.16

0.18

3.4

2.9

93.0

67.3

ug/l

0.57

277

(3048689) Calprotectin [Mass/mass] in Stool

1.16

0.16

1.0

2.1

53.4

85.4

ug/g

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.79

0.15

1.8

1.6

—

(3015736) pH of Urine

210

1.15

0.14

3.0

3.2

—

(42870588) Differential panel, method unspecified - Blood

173

1.14

0.12

3.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

164

1.13

0.11

1.4

—

(3019150) Specific gravity of Urine by Refractometry

116

1.15

0.10

4.2

3.7

1.0

kg/l

—

(1761868) Lipid panel - Serum or Plasma

264

1.10

0.10

2.6

2.3

—

(3000494) Fungus identified in Specimen by Culture

0.79

0.08

1.0

1.3

—

(3022145) Colonoscopy Study observation

1.03

0.08

1.4

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

381

0.94

0.05

4.2

3.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

471

1.07

0.03

3.1

3.6

—

(3032080) INR in Blood by Coagulation assay

163

1.06

0.01

3.5

7.3

1.2

1.0

inr

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

584

1.09

0.00

12.4

10.8

13.1

18.0

mg/l

1.11

439

(3027315) Oxygen [Partial pressure] in Blood

0.00

0.0

2.3

—

9.9

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.0

1.0

—

(3045424) Erythrocytes [Presence] in Urine

0.00

0.0

1.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

19.5

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

466.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

0.0

2.3

—

4.8

—

(3034426) Prothrombin time (PT)

0.00

0.0

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

0.00

0.0

1.3

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

0.0

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.0

2.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

5.6

—

18.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

0.0

2.0

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.0

3.6

—

5.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

0.92

0.00

1.0

1.5

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

0.0

1.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

221.2

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.0

1.5

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.0

3.6

—

0.9

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

0.0

1.6

—

92.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(3036603) Volume of Urine

0.00

0.0

1.4

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.0

5.0

—

(4281824)

0.00

0.0

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

0.0

1.9

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.00

0.0

1.0

—

7.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

(3024928) Oxygen saturation in Venous blood

0.00

0.0

1.3

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.0

28.6

—

2870.2

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

0.0

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.95

0.00

2.0

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.0

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.0

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

0.0

1.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.0

1.9

—

6.8

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

14.0

—

1335.0

—

(3044941) Cell count panel - Synovial fluid

0.00

0.0

1.7

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

0.0

1.7

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.0

1.3

—

49.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

0.0

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(3015183) Erythrocyte sedimentation rate

0.00

0.0

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.0

—

31.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.0

2.1

—

63.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.91

0.00

1.8

1.5

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

0.0

2.7

—

2.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (not available in FinRegistry).

Relationships between endpoints

↥

Index endpoint: L12_HIRSUTISM_ADVERSE – Hirsutism, drug-induced

GWS hits: -

This endpoint is excluded (not available in FinRegistry).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Hirsutism, drug-induced

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Hirsutism, drug-induced (L12_HIRSUTISM_ADVERSE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints